# Bivalirudin

NDC: 55111-652
Generic name: Bivalirudin
Labeler / Manufacturer: Dr. Reddy's Laboratories Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRACAVERNOUS
Marketing started: 20170531

FDA application: ANDA201577

## Active ingredients

- BIVALIRUDIN: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55111-652"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55111-652
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=19beb2ae-6064-3c24-fe50-0cee86896979